Unity price target raised to $32 from $26 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Unity (U) to $32 from $26 and keeps an Overweight rating on the shares. Unity will start ...
Unity Software (U) Q4 2024 Earnings Call Transcript
My name is Daniel Meyer, VP and head of investor relations. Our earnings press release and investor spreadsheet is now ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
News Medical3d
Human organoids for AAV capsid selection
Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...
AZoNano4d
Non-Invasive Particle Size Monitoring of Polymer-Based Vectors for Cell Transfection in Process Vessels
Accurate monitoring of particle size and growth is essential to ensure scalability in the development of transfection vectors ...